EMA Highlights: WHO and EU link up to boost public health
by Gary Finnegan: EU agencies are stepping up cooperation with the World Health Organization (WHO) to share information on the safety, quality and efficacy of medicines.
by Gary Finnegan: EU agencies are stepping up cooperation with the World Health Organization (WHO) to share information on the safety, quality and efficacy of medicines.
by Gary Finnegan: The chair of the European Medicine Agency’s most influential committee has been re-elected for a three-year term. The Committee for Medicinal Products for Human Use… read more.
by Gary Finnegan: The European Medicines Agency’s key committee approved a total of 19 new medicines at its meeting in late September – the highest number of products… read more.
Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.
Early intervention facilitated by a digital health application for reporting symptoms of Chronic Obstructive Pulmonary Disease (COPD) provides key benefits for patients, according to the results of a… read more.
A study published in Nature by Jos Lelieveld and colleagues at the Max Planck Institute for Chemistry, in Mainz, Germany, found that although air pollution has several causes,… read more.
In one of the largest population studies on pain to date, researchers with the National Institutes of Health estimate that nearly 40 million Americans experience severe pain and… read more.
An increase in fat mass index (FMI), but not body mass index (BMI), was associated with both prevalent and future foot pain, a large community-based study showed.
Firmagon (Degarelix) is a competitive, reversible GnRH receptor blocker, for patients with advanced hormone-dependent prostate cancer. Where Injection technique is critical; Nora Sullivan, a specialist nurse at Hibernian… read more.
Dynamic leg muscle power is an independent determinant of pain and quality of life in knee osteoarthritis (OA), and it appears to outperform muscle strength as a measure… read more.
Despite improvements in rheumatoid arthritis (RA) management, pain control remains inadequate in some patients even when inflammation is well controlled, according to a small Dutch study.
A recent review found that most newborns that are included in control groups during clinical trials concerning minor painful procedures are denied analgesia, despite international guidelines stating that… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.